Minerva Biotechnologies
Pre-clinicalMinerva Biotechnologies is developing therapies for curing cancers and commercializing core technology that will enable next generation stem cell therapies.
Founded
1999
Focus
AntibodiesBiologicsSmall Molecules
About
Minerva Biotechnologies is developing therapies for curing cancers and commercializing core technology that will enable next generation stem cell therapies.
Funding History
2Total raised: $25.2M
Series A$25MMorningside VenturesJun 15, 2020
Grant$200KNational Cancer InstituteJun 15, 2019
Company Info
TypePrivate
Founded1999
LocationWaltham, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile